Vertex Pharmaceuticals (VRTX)

Total Costs & Expenses

$7.75B

TTM · Period ending: · USD

VRTX logo

VRTX Total Costs & Expenses

Latest reported$7.75B
VRTX TTM Total Costs & Expenses (-$6.40M → $7.75B)
High-resolution chart · PNG

VRTX total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
7,752,700,000
7,479,300,000
7,770,600,000
7,729,900,000
7,495,300,000
11,842,000,000
11,253,000,000
10,896,200,000
10,686,000,000
5,992,500,000
6,037,200,000
5,777,200,000
5,539,400,000
5,162,500,000
4,623,300,000
4,551,000,000
4,271,852,000
5,013,252,000
4,797,031,000
4,481,659,000
4,417,437,000
3,392,589,000
3,345,493,000
3,324,265,000
3,307,571,000
3,172,452,000
2,960,796,000
2,813,876,000
2,545,400,000
2,453,284,000
2,383,631,000
2,195,761,000
2,265,232,000
2,173,920,000
2,095,823,000
1,989,155,000
1,776,126,000
1,716,133,000
1,693,979,000
1,747,035,000
1,689,549,000
1,596,749,000
1,498,792,000
1,320,911,000
1,223,242,000
1,207,656,000
1,222,541,000
1,275,585,000
1,338,948,000
1,386,329,000
1,411,395,000
1,475,610,000
1,468,281,000
1,529,855,000
1,522,866,000
1,450,036,000
1,451,767,000
1,302,859,000
1,188,932,000
1,084,901,000
969,306,000
888,816,000
837,946,000
774,982,000
724,881,000
700,922,000
694,668,000
696,250,000
685,186,000
669,784,000
633,888,000
603,319,000
595,894,000
599,082,000
611,685,000
597,382,000
557,456,000
503,051,000
441,743,000
397,334,000
360,457,000
324,612,000
302,628,000
286,789,000
270,521,000
256,799,000
239,950,000
290,716,000
291,069,000
338,714,000
289,874,000
248,643,000
257,561,000
217,334,000
280,689,000
267,929,000
258,572,000
231,107,000
198,801,000
168,218,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.